Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVJF) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to 0.29%.

  • Teva Pharmaceutical Industries' Return on Invested Capital rose 4000.0% to 0.29% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.29%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 0.29% for FY2025, which is 3500.0% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Return on Invested Capital stood at 0.29% for Q4 2025, which was up 4000.0% from 0.18% recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Return on Invested Capital registered a high of 0.29% during Q2 2025, and its lowest value of 0.24% during Q1 2021.
  • For the 5-year period, Teva Pharmaceutical Industries' Return on Invested Capital averaged around 0.01%, with its median value being 0.03% (2024).
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Return on Invested Capital tumbled by -2400bps in 2022 and then skyrocketed by 4000bps in 2025.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Return on Invested Capital stood at 0.09% in 2021, then plummeted by -275bps to 0.15% in 2022, then skyrocketed by 130bps to 0.05% in 2023, then tumbled by -338bps to 0.11% in 2024, then skyrocketed by 359bps to 0.29% in 2025.
  • Its Return on Invested Capital was 0.29% in Q4 2025, compared to 0.18% in Q3 2025 and 0.29% in Q2 2025.